Visby Medical Receives FDA Clearance for the First At-Home PCR for Multiple Respiratory Viruses
Visby Medical, the at-home diagnostics company, today announced U.S. Food and Drug Administration (FDA) clearance for the Visby Medical Flu and COVID-19 Test, the first multi-viral at-home PCR test. This marks Visby’s second over-the-counter PCR test and expands the company’s growing portfolio of rapid molecular diagnostics designed for home use.
Visby Medical and RAINN Launch Safe Access Program, Bringing Private, Lab-Accurate STI Testing to Sexual Assault Survivors
Visby.com, and RAINN, the nation’s largest anti-sexual violence organization, today announced the launch of the Safe Access Program — a national initiative to provide survivors of sexual assault with private, clinically accurate sexually transmitted infection (STI) testing they can use at home, without a clinic visit, a waiting room, or an explanation to anyone.
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs
Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test, the first, at-home, FDA-authorized PCR test for sexually transmitted infections (STIs) available to consumers, enabling immediate access to Visby’s integrated "Test-to-Treat" ecosystem. The palm-sized device delivers confidential results in just 30 minutes, providing women with a rapid response for chlamydia, gonorrhea, and trichomoniasis from the comfort and privacy of the home.
Visby Medical Tackles STI Epidemic with First At-Home FDA-Authorized PCR Test in Partnership with Google Cloud
Visby Medical today announced the national launch of the first-of-its-kind FDA-authorized at-home PCR test for sexually transmitted infections (STIs) in women, redefining how sexual health is diagnosed and treated. The palm-sized test, now available nationwide with seamless virtual care support and rapid home delivery, accurately detects three of the most common and often asymptomatic infections—chlamydia, gonorrhea, and trichomoniasis—in just 30 minutes.
